Navigation Links
BioAtom Inc. To Present at BIOCOM Investor Conference 2008
Date:10/26/2008

SAN DIEGO, Oct. 27 /PRNewswire/ -- BioAtom Inc. (private) announced today that it will present at the 3rd annual BIOCOM Investor Conference on Tuesday, October 28, 2008 at 2:30 PM PDT (5:30 PM EDT) at the Hyatt Regency La Jolla in San Diego, California.

Myron Karasik, M.B.A., C.M.C., Director of Finance, will present an overview of Medical Division of BioAtom Inc. of Costa Mesa, CA, dedicated to development and commercialization of Neutron Cancer Diagnostics. Its ONCOSENSOR(TM), a nanotechnology probe, will undergo in vivo evaluation at Center for Functional Onco Imaging, UC Irvine, in collaboration with Radiation Oncology Group, Long Beach Memorial Hospital.

From Bomb Detector to Cancer Diagnostic Probe. Malignant tumors are chemically different from normal tissue. ONCOSENZOR(TM) can non-invasively detect in vitro chemical differences as small as 1 atom/molecule. Its core technology was developed under US Army contracts for non-intrusive detectors of bioagents and explosives in a previous company (no longer in existence), by co-founders of BioAtom, at a cost to shareholders of over $40 million.

Our mission is to provide an early warning, walk-in, painless (non-invasive) and "instant" (online) cancer diagnosis aid that is a quantum leap ahead of competing firms. Operating in tandem with any one of the imaging probes, we hope to ultimately achieve needle-less biopsy. The method has the potential for forewarning of stroke, Alzheimer, and cardiovascular diseases.

Marketing of ONCOSENZOR(TM) to animal clinics, a $13 Billion/year market, does not require FDA approval.

Anna Radovic, Ph.D., 36, President and Chief Scientific Officer, an international cancer researcher and co-patentee, was first to irradiate DNA by neutrons. Christian Druey, B.E.E., 38, has been instrumental in commercialization of medical imaging and explosive detection devices. Bogdan Maglich, Ph.D., CTO and Chairman, the inventor of the core technology, has been
'/>"/>

SOURCE BioAtom Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Oncothyreon to present at BIO Investor Forum 2008
2. China Yingxia to Present at Rodman & Renshaw Annual Global Investment Conference
3. Significant Anti-Tumor Activity and Extended Half-Life of NKTR-102 (PEG-irinotecan) Highlighted in Phase 1 Data Presented at EORTC-NCI-AACR Symposium
4. Amylin Pharmaceuticals to Present at BIOCOM Investor Conference
5. Oncolytics Biotech Inc. Collaborators to Present Combination REOLYSIN(R) and Paclitaxel/Carboplatin Results at iSBTc Annual Meeting
6. Oncolytics Biotech Inc. Collaborators to Present Combination REOLYSIN(R) and Docetaxel Results at iSBTc Annual Meeting
7. MedImmune Presents Data Highlighting its Progressive Inflammatory Disease Portfolio at the 72nd Annual Meeting of the American College of Rheumatology
8. New Clinical Studies Presented at the American Society of Anesthesiology (ASA) Annual Meeting Show Masimo Technologies Provide Advanced Clinical Intelligence
9. Celator(R) Pharmaceuticals To Present at 2008 BIO Investor Forum
10. Rosetta Genomics to Present at the Upcoming EORTC-NCI-ASCO Annual Meeting on "Molecular Markers in Cancer"
11. Oncolytics Biotech Inc. Collaborators Present Reovirus and Melanoma Research at EORTC-NCI-AACR Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... , July 24, 2014  Now available is a ... Rehealth Regenerative Therapies , located in ... physically active people a new health option: stem ... of age, countless patients suffer from joint and muscle ... as muscle tears, torn rotator cuff, tennis elbow, and ...
(Date:7/24/2014)... led by group leader Yung-Eun Sung has announced ... sulfur-doped and nitrogen-doped graphenes which can be applied ... fuel cells. Yung-Eun Sung is both a group ... Institute for Basic Science* (IBS) and a professor ... has great significance with regards to the development ...
(Date:7/24/2014)... Research and Markets has announced ... 2014-2018" report to their offering.  ... the in vitro growth of plant or animal cells ... biopharmaceutical production. Cell culture is a crucial step in ... cell culture consumables are necessary for the in vitro ...
(Date:7/24/2014)... N.J. , July 24, 2014  CorMedix ... on developing and commercializing therapeutic products for the ... today announces receipt of notice on July 18, ... the NYSE-MKT has accepted the CorMedix plan to ... NYSE-MKT. As a result, the NYSE-MKT is continuing ...
Breaking Biology Technology:Stem Cells In Sports Injuries, Joints And Muscular Pain 2Stem Cells In Sports Injuries, Joints And Muscular Pain 3Global Cell Culture Market 2014-2018: Key Vendors are Becton, Dickinson and Co, EMD, GE Healthcare, Lonza Group, Sigma Aldrich and Thermo Fisher Scientific 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 3
... 14, 2011 VIVUS, Inc. (NASDAQ: VVUS ... phase 3 long-term safety and efficacy study of the ... (ED), was presented over the weekend at the 2011 ... Las Vegas, NV.  Andrew R. McCullough, MD, Professor of ...
... Pharmasset, Inc. (Nasdaq: VRUS ) announces that management ... Conference to be held November 15 to 16, 2011 at ... Chief Executive Officer, will provide an overview of the company ... To access a simultaneous webcast of Mr. Price,s overview via ...
... (the "Company") (NASDAQ and MTA: CTIC) announced today the ... held on Friday, November 11, 2011. At ... Vartan Gregorian, Ph.D., and Frederick W. Telling, Ph.D. to ... the Company, s 2014 Annual Meeting. Shareholders also elected ...
Cached Biology Technology:15-Minute Data From Phase 3 Study of Avanafil Featured as a Late Breaking Abstract at SMSNA Annual Meeting 215-Minute Data From Phase 3 Study of Avanafil Featured as a Late Breaking Abstract at SMSNA Annual Meeting 315-Minute Data From Phase 3 Study of Avanafil Featured as a Late Breaking Abstract at SMSNA Annual Meeting 4Pharmasset to Present at the Lazard Capital Markets Healthcare Conference 2Pharmasset to Present at the Lazard Capital Markets Healthcare Conference 3Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders 2
(Date:7/24/2014)... This news release is available in German . ... has evolved to recognize and respond to threats to ... disease. A detailed understanding of the mechanism underlying immunologic ... of research have converged to support the hypothesis that ... of immune cells with stem-cell-like potential. Until now, there ...
(Date:7/23/2014)... , July 24, 2014 Pfenex Inc. (NYSE MKT: ... of 8,333,333 shares of its common stock at a price ... has granted the underwriters a 30-day option to purchase up ... public offering price. The shares are expected to begin trading ... symbol "PFNX". William Blair & Company, ...
(Date:7/23/2014)... Environmental Protection Agency (EPA) today announced that environmental ... Massachusetts Amherst School of Public Health and Health ... to Achieve Results (STAR) grant to measure indoor ... hunters in subarctic North America to determine possible ... provide culturally-relevant recommendations for mitigation. , Peltier, who ...
Breaking Biology News(10 mins):Experiments prove 'stemness' of individual immune memory cells 2Experiments prove 'stemness' of individual immune memory cells 3Pfenex Inc. Announces Pricing Of Initial Public Offering 2Studying impacts of indoor air pollution on tribal communities 2Studying impacts of indoor air pollution on tribal communities 3
... Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing ... today announced the presentation of data from its recently ... augmentation (add-on) treatment in subjects with major depressive disorder, ... treatment with the representative SSRI citalopram hydrobromide. In ...
... learn more? You probably aren,t watching television then. A ... Zhao suggests that watching television has no significant impact ... Reading newspapers and using the web, however, seem to ... study, "Media Use and Global Warming Perceptions: A Snapshot ...
... Adhering to the undersides of vessels, carpets of the crustaceans ... owners would love to know how to stop these hitchhikers ... an adhesive, you have to understand the curing process. Curious ... Duke University decided to find out how barnacle adhesive polymerizes. ...
Cached Biology News:Targacept's P.2b depression study succeeds: 6-point difference on HAM-D 2Targacept's P.2b depression study succeeds: 6-point difference on HAM-D 3Television has less effect on education about climate change than other forms of media 2Super sticky barnacle glue cures like blood clots 2Super sticky barnacle glue cures like blood clots 3
... Guava PCA-96 systems provide automated, higher throughput ... of microcentrifuge tubes. This flexible sample format ... screening in basic research, target validation, assay ... smaller cousin, the Guava PCA-96 uses a ...
... antibody irreversibly crosslinked to protein G-agarose beads ... complex from heart mitochondria. Also included are ... control immunocapture. ,The pyruvate dehydrogenase complex (PDH) ... small amounts of tissue. This facilitates the ...
... of a protein into cells permits studies ... pathways, apoptotic pathways, and transcription factor-mediated gene ... the effects of a specific protein in ... protein directly into the cell. ProteoJuice Protein ...
... BD FACSVantageTM SE flow cytometry system is ... laboratory. For over 25 years, BD cell ... are found in leading university, pharmaceutical, and ... To meet the research demands of today, ...
Biology Products: